Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights From a Western Single‐Center Study
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.27955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Francisco Nolasco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Liver Surgery Unit, Department of Gastroenterology, Digestive Surgery Division, University of Saão Paulo Medical School, São Paulo, Brazil. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Carcinoma, Hepatocellular, Liver Neoplasms, Bile Duct Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Introduction
Primary liver malignancies, such as hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular‐cholangiocarcinoma (cHCC‐CCA), represent significant contributors to global cancer‐related mortality. The diagnostic challenges associated with distinguishing cHCC‐CCA from HCC and ICC stem from their rarity and overlapping histological features.
Objectives
This study aimed to reclassify primary liver tumors resected at a Western center and to compare clinicopathological features and prognosis among patients with HCC, ICC, and cHCC‐CCA.
Methods
A retrospective analysis was conducted on patients undergoing resection for HCC, ICC, or cHCC‐CCA between 2007 and 2017. Clinical and perioperative data were collected, and pathological specimens were reclassified by a specialized pathologist. Statistical analysis was employed to compare clinical features and survival outcomes among the different tumor types.
Results
Out of the initially identified 192 patients, 140 were included in the analysis. Following reclassification, 71.42% were diagnosed with HCC, 12.14% with ICC, and 16.42% with cHCC‐CCA. Patients with HCC were predominantly male and exhibited a higher incidence of isolated liver recurrence. ICC patients more frequently underwent open procedures. Additionally, patients with HCC and cHCC‐CCA showed higher rates of cirrhosis, elevated alpha‐fetoprotein levels, and extrahepatic recurrence, while those with ICC and cHCC‐CCA demonstrated elevated CA 19‐9 levels. Overall survival and disease‐free survival were longer for HCC compared to cases with a cholangiolar component (ICC and cHCC‐CCA).
Conclusions
Histological evaluation should actively incorporate the search for a cholangiolar component in primary liver tumors to prevent misdiagnosis, as its presence indicates a poorer prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Liver Surgery Unit, Department of Gastroenterology, Digestive Surgery Division, University of Saão Paulo Medical School, São Paulo, Brazil.
- Departament of Pathology, University of São Paulo Medical School, São Paulo, Brazil.
Zitieren
APA
Nolasco, F., Fonseca, G. M., de Mello, E. S., Kruger, J. A. P., Jeismann, V. B., Makdissi, F. F., Coelho, F. F., Alves, V. A. F., & Herman, P. (2025). Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights From a Western Single‐Center Study. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27955
Vancouver
Nolasco F, Fonseca GM, de Mello ES, Kruger JAP, Jeismann VB, Makdissi FF, et al. Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights From a Western Single‐Center Study. Journal of Surgical Oncology. 2025. doi:10.1002/jso.27955
BibTeX
@article{Nolasco2025,
author = {Nolasco, Francisco and Fonseca, Gilton Marques and de Mello, Evandro S and Kruger, Jaime Arthur Pirolla and Jeismann, Vagner Birk and Makdissi, Fabio Ferrari and Coelho, Fabricio Ferreira and Alves, Venancio A F and Herman, Paulo},
title = {Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights From a Western Single‐Center Study},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.27955}
}
EUVIMED